Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

Anti-B-cell maturation antigen therapies consisting of bispecific antibodies, antibody–drug conjugates, and chimeric antigen receptor T cells have shown promising results in relapsed refractory multiple myeloma (RRMM). However, the severe side effects include cytokine release syndrome, immune effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanam, Razwana, Faiman, Beth, Batool, Saba, Najmuddin, Mohammed Musa, Usman, Rana, Kuriakose, Kiran, Ahmed, Arooj, Rehman, Mohammad Ebad Ur, Roksana, Zinath, Syed, Zain, Anwer, Faiz, Raza, Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487885/
https://www.ncbi.nlm.nih.gov/pubmed/37685606
http://dx.doi.org/10.3390/jcm12175539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487885/
https://www.ncbi.nlm.nih.gov/pubmed/37685606
http://dx.doi.org/10.3390/jcm12175539

Ejemplares similares